NLARx News
FTC Asked to Investigate CVS Caremark for Violation of Consumer Protection & Competition Laws More
NLARx Wants Agency to Probe CVS More
|
In the States
VERMONT: Legislature Acts to Make Drug Makers' Gifts Public More
State Wants Data on Payments More
State Strengths Disclosure Law More
MAINE: Bill to Ban Predatory Marketing to Minors Enacted More
WASHINGTON: State Drops Cut to Medicaid Pharmacy Payments More
TEXAS: Legislature Poised to Pass Important PBM Transparency Provisions More
OHIO: Rep. Skindell Reintroduces HB 94,
the Ethical Marketing Disclosure Act More
TENNESSEE: State Enacts PBM Transparency Law More |
Outrages of the Week
Justice Dept., 16 States Allege Wyeth Cheated Medicaid Programs Out of "Hundreds of Millions of Dollars" More
Merck Makes Phony Peer-Review Journal More
|
Prices and Access to Healthcare
Spike in Branded Drug Prices Drives Hike in Overall Drug Spending MoreGenerics Help Offset Branded Drug Price Hikes More |
Patents and Generics
Generic Drugs Saved US Health Care $734 Billion in Last Decade More
Biotechs in Favor of Streamlining Generic Drug Approvals More
Gilead Slaps Teva With Another Patent Suit More
Abbott Sues J&J Over Humira Rival More
Will Cipla's 'Antiflu' Prompt Mass Patent-Waiving? More
Medical Organizations
Challenge Gene Patents' Constitutionality More
|
Conflicts of Interest
J&J Endorses Physician Sunshine Act More
NIH Considers Expanding Regs
On Grantees' Financial Conflicts More
NIH Seeks Public Input on Managing Conflicts of Interest More
Are Conflicts of Interest in Cancer Clinical Research the Real Problem? More
Pharma, Academia Ties Difficult to Unwind More
An Academia-Industry Partnership in Health Care More
Medtronic Unresponsive in Grassley Probe of False Data More
Grassley Raises Total of Undisclosed Fees Paid to Professor by Glaxo More
Time for the Medical Profession to Act More
|
Advertising and Marketing
Exposure to Small Pharmaceutical Promotional Items on Treatment Preferences More
Institute of Medicine Warns About Physician-Pharma Conflicts of Interest More
Online Advertising Growth Slows in 2008, Search Declines in 2009 More
IMS: Drug Cost Should Re-Allocate $15B In Promotional Spending More
After FDA Warning, J&J Yanks Online Video for Pain Medicine More
Reprints: Another Example of FDA Flexing Its Enforcement Muscles More
Did Astrazeneca Plan to Tout Seroquel Off-Label? More
Celebrity Patient's Backing Turns Sour for BMS More
Behrman Wasn't the First Patient Spokesperson Paid Big Bucks By BMS More
Merck, Elsevier, and Fakery More
When Is A "Journal" Not A Journal? More
Will the Drug Industry be the Next Auto Industry? More
|
Pharma Watch
Prescription Drug Use Dropped in 2008, Though Spending Increased More
Lobbyists Get $47.4M Windfall from Pharma More
Top 15 Big Pharma Paychecks of 2008 More
Big Pharma Firms Strike Deals With Generic Firms More
Industry Groups Reiterate Commitment To Reduce Health Spending Growth More
PhRMA Statement on Healthcare Reform Coalition More
Industry Groups Say White House Overstated Their Pledge More
FDA Insider Joins Pfizer More
Eli Lilly CEO Makes Case Against Public Health Insurance Plan More
Pfizer Offers Free Drugs to the Newly Unemployed More
No Such Thing as Free Drugs? More
The Deafening Silence More
Pharma Emerging-Market Numbers Fall Short More
|
PBM Watch
CVS Appears to Steer Plan Patients to Its Stores More
Independent Pharmacists Raise Concerns Over Anti-competitive Practices by CVS Caremark More
Group Targeting CVS Caremark 'Hopeful' After FTC Meeting
More
Advocates Blast CVS For Alleged Consumer Protection Violations More
|
Comparative Effectiveness Research
Coalition Proposes Independent Panel To Oversee Comparative Effectiveness More
New Comparative Effectiveness Paradigm
Outlined in Report More
Supporters, Opponents of Comparative Effectiveness Research Gearing More
PhRMA Tries to Keep 'Comparative Effectiveness' in Check More
|
Medicare
Medicare Recipients Subject to Higher Premiums for Parts B and D in 2010 More
AARP Ramps Up Effort To Close Medicare Doughnut Hole More
Department of Justice, HHS Boosts Number of Investigators, Prosecutors Looking at Medicare, Medicaid Fraud More
|
Medicaid
Feds Join Lawsuits Against Wyeth on Protonix Prices for Medicaid More
Medicaid Guidelines for Prescribing Psychiatric Drugs to Kids Leads to Decline in Use More
WellCare Pays Another $10 Million Over Medicaid Fraud Probes More
|
Safety and Clinical Trials
Investigation by Walter Reed Center Questions Validity of Doctor's Research on Bone-Growth Protein in Leg Fractures MorePlaintiffs Say AstraZeneca Documents Discuss Promoting Seroquel for Unapproved Uses in Children and Elderly MoreWrangling Over Research Results MoreDelaware Deaths Spark Heparin Probe MoreObama Wants to Boost FDA Budget 19% MoreWhen Is an Old Drug Better Than New? MoreFDA Requires Strong Warnings on Two Testosterone Gels MoreCardiologists Warn on Plavix Plus PPI MoreKids Take More Drugs for Diabetes, Attention Deficit More |
Executive Branch Appointments
Peggy Hamburg Confirmed to Lead FDA More
|
Electronic Records
Lobbying Efforts of Health Information Technology Industry More
Hacking of Prescription Database May Lead to Headaches More
PhRMA's Billy Tauzin Talks From Experience on Electronic Records More
|
